Ribonuclease A from bovine pancreas
MerckType III-A, ≥85% RNase A basis (SDS-PAGE), 85-140 Kunitz units/mg protein
Type III-A, ≥85% RNase A basis (SDS-PAGE), 85-140 Kunitz units/mg protein
SelectScience® brought a grand piano to the Pittcon show floor for the first time ever
This special feature explores the latest research, applications, and advances in cell-based assay technology
Joint HORIBA and AIST-NT Solution Provided Spatial Resolution below 15 nm
Meet Dr. Ron Daniels, a #CLINICAL24 Ambassador, and discover his tireless fight to improve sepsis diagnostics and care
A proprietary surface treatment of RSA™ vials to a permanent hydrophobic state that won’t degrade with time or in the presence of water. This treatment renders the hydrophobic glass surface very hydrophobic and hydrolytically stable that won’t bleed or leach into your chromatograms.
Reversed-Phase nano columns for proteomics
Learn about the future of newborn screening in this guest editorial from Clinical and Laboratory Standards Institute
Find out how to unlock cellular mysteries with Yokogawa’s Single Cellome™ System SS2000
In this guest editorial by Thermo Fisher Scientific, learn about the steps you can take to unleash the power of digital transformation to optimize your scientific workflows
Discover the key benefits of automation for streamlining clinical flow cytometry and explore the positive impact this can have on patient care
Report identifies need for improved assays across numerous disease areas and more education around LC-MS/MS technologies
BalanCD™ Transfectory CHO is a chemically defined transient expression system designed for rapid, scalable recombinant protein production in CHO cells. Supporting both small- and large-scale transient transfection workflows, it enables milligram-to-gram protein yields while helping streamline development and facilitate progression toward commercial manufacturing.
ELRIG’s Impact Award, supported by SelectScience, is presented to an early career professional who has made a significant impact in the drug discovery community